asia healthspace

Hospital markets country briefs China   We have explored the many trends driving the growth in China’s healthcare market in the above sections. With the recent policy change allowing 100% non-Chinese ownership of hospitals and other health services, foreign and private ventures in China’s healthcare sector is projected to increase over time. In fact, the [...]

Part 3 of the report Asia healthcare Titans 2013 from Clearstate Pte Ltd. Source: More than 10% stake, deal worth more than US$ 15 million, target country Asia. Unless otherwise indicated, source: Bloomberg & EIU Zephyr databases Tej Deol, M.D.

Supply drivers and trends in Asia   Strong demand inadequately met by current infrastructure At 2.08 beds and 1.09 doctors per 1,000 population, Asia and Australasia lags behind the global average (2.72 and 1.72 respectively, refer to Figure 6 below).[i] As Asia continues in its growth trajectory, demand will continue to outstrip supply. The market [...]

Demand drivers and trends in Asia GDP growth drives healthcare spending   With real GDP growth rates almost double the global average (5.70% compared to 2.30%[i]), Asia will be a prime driver of global economic growth going forward. At real GDP growth in the range of 5–8% in Asia annually, and with healthcare projected to [...]

The following series of posts describing the current landscape in the Hospital sector in prominent Asia Pacific markets are derived from a proprietary report developed by Clearstate. Clearstate, an Economist Intelligence Unit healthcare business, is the market leader in healthcare research-based consulting in the emerging markets. The analysis and content in this report is derived [...]

Malaysia’s government undergoing a strong push to extend national healthcare capabilities with emphasis on continued healthcare infrastructure development, as the National healthcare ecosystem is developed to propel economic growth. This initiative will include the planned construction of new hospitals and specialized facilities, including eight new hospitals, 156 rural clinics, 41 community health clinics, and 50 [...]

A highly heterogeneous region, Asia has established itself as one of the most exciting and challenging markets across many industries, but particularly so for healthcare products and services. Beyond price affordability issues, logistical challenges, and the regulatory labyrinths, many parts of Asia are also plagued by cultural barriers, especially for women’s health management. The lack [...]

Overview Lower limb peripheral artery disease landscape Lower limb peripheral artery disease (PAD) or peripheral vascular disease (PVD) is a cardiovascular disease that leads to narrowing and hardening of arteries found outside the coronary, aortic arch and brain.  With an estimated 10 million people in these markets who are diagnosed with lower limb PAD annually, [...]

In this post I provide for your benefit a snapshot summary of the on-going healthcare reforms being undertaken in China courtesy of a report from Ernst and Young titled “Progressions Pharma 3.0; A Global Pharmaceutical report 2010″ as well as a smart article by Wharton Business School published on March 30, 2011, on the Knowledge [...]

First of all, a big thank you to the folks at asiahealthspace.com for the warm welcome. I am very much looking forward to contributing to the space. In the next 2 – 3 years the much talked about patent cliff in the pharmaceutical industry will gain real momentum and traction. Some estimates value the impending [...]